Relevant bibliographies by topics / Antiangiogenic therapy / Books
To see the other types of publications on this topic, follow the link: Antiangiogenic therapy.

Books on the topic 'Antiangiogenic therapy'

Author: Grafiati
Published: 4 June 2021
Last updated: 3 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 15 books for your research on the topic 'Antiangiogenic therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Teicher, Beverly A., ed. Antiangiogenic Agents in Cancer Therapy. Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-453-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Teicher, Beverly A., and Lee M. Ellis, eds. Antiangiogenic Agents in Cancer Therapy. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-184-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Teicher, Beverly A. Antiangiogenic Agents in Cancer Therapy. Humana Press, 1998. http://dx.doi.org/10.1385/0896036413.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Li, William W. The antiangiogenic therapy self help book for cancer patients. Angiogenesis Foundation, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

(Editor), Darren W. Davis, Roy S. Herbst (Editor), and James L. Abbruzzese (Editor), eds. Antiangiogenic Cancer Therapy. CRC, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1971-, Davis Darren W., Herbst Roy, and Abbruzzese James L, eds. Antiangiogenic cancer therapy. CRC Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Antiangiogenic cancer therapy. CRC Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1952-, Teicher Beverly A., and Ellis Lee M, eds. Antiangiogenic agents in cancer therapy. 2nd ed. 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

1952-, Teicher Beverly A., and Ellis Lee M, eds. Antiangiogenic agents in cancer therapy. 2nd ed. 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Teicher, Beverly A., and Lee M. Ellis. Antiangiogenic Agents in Cancer Therapy. Humana, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

1952-, Teicher Beverly A., ed. Antiangiogenic agents in cancer therapy. Humana Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

1952-, Teicher Beverly A., and Ellis Lee M, eds. Antiangiogenic agents in cancer therapy. 2nd ed. 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

1952-, Teicher Beverly A., and Ellis Lee M, eds. Antiangiogenic agents in cancer therapy. 2nd ed. 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

(Editor), Beverly A. Teicher, and Lee M. Ellis (Editor), eds. Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development). 2nd ed. Humana Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Eisen, Tim. The patient with renal cell cancer. Edited by Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0172.

Full text
Abstract:
Renal cancer is the commonest malignancy of the kidney and worldwide, accounts for between 2% and 3% of the total cancer burden. The mainstay of curative treatment remains surgery. There have been significant advances in surgical technique, the most important ones being nephron-sparing surgery and laparoscopic nephrectomy. The medical treatment of advanced renal cell cancer has only improved markedly in the last decade with the development of antiangiogenic tyrosine-kinase inhibitors, inhibitors of mammalian target of rapamycin, and a diminished role for immunotherapy.Tyrosine-kinase inhibitor
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Antiangiogenic therapy' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography